PaxMedica Common Stock Statistics Share Statistics PaxMedica Common Stock has 125.63M
shares outstanding. The number of shares has increased by 1514.86%
in one year.
Shares Outstanding 125.63M Shares Change (YoY) 1514.86% Shares Change (QoQ) 1054.81% Owned by Institutions (%) 2.02% Shares Floating 10.36M Failed to Deliver (FTD) Shares n/a FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 637.72K, so undefined% of the outstanding
shares have been sold short.
Short Interest 637.72K Short % of Shares Out n/a Short % of Float 6.15% Short Ratio (days to cover) 0.1
Valuation Ratios The PE ratio is -0.07 and the forward
PE ratio is -0.03.
PaxMedica Common Stock's PEG ratio is
0.
PE Ratio -0.07 Forward PE -0.03 PS Ratio 0 Forward PS n/a PB Ratio 0.37 P/FCF Ratio -0.12 PEG Ratio 0
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for PaxMedica Common Stock.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 3.16,
with a Debt / Equity ratio of 0.
Current Ratio 3.16 Quick Ratio 3.16 Debt / Equity 0 Debt / EBITDA n/a Debt / FCF n/a Interest Coverage -1761.62
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-3.05M Employee Count 6 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by null% in the
last 52 weeks. The beta is -0.56, so PaxMedica Common Stock's
price volatility has been lower than the market average.
Beta -0.56 52-Week Price Change n/a 50-Day Moving Average 0.01 200-Day Moving Average 0.11 Relative Strength Index (RSI) 37.16 Average Volume (20 Days) n/a
Income Statement
Revenue n/a Gross Profit n/a Operating Income -16.15M Net Income -18.29M EBITDA -16.15M EBIT -18.28M Earnings Per Share (EPS) -11
Full Income Statement Balance Sheet The company has 4.71M in cash and 0 in
debt, giving a net cash position of 4.71M.
Cash & Cash Equivalents 4.71M Total Debt n/a Net Cash n/a Retained Earnings -52.03M Total Assets 799.61K Working Capital -1.31M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -10.77M
and capital expenditures 0, giving a free cash flow of -10.77M.
Operating Cash Flow -10.77M Capital Expenditures n/a Free Cash Flow -10.77M FCF Per Share -6.48
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields PXMD does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast Currently there are no analyst rating for PXMD.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Oct 31, 2023. It was a
backward
split with a ratio of 1:17.
Last Split Date Oct 31, 2023 Split Type backward Split Ratio 1:17
Scores Altman Z-Score -167.51 Piotroski F-Score 2
